Long-term cerebrovascular effects of cyclophosphamide and vincristine: endothelial senescence, impaired DNA repair signaling, and blood-brain barrier dysfunction.
Key claim: In mice, clinically relevant cyclophosphamide induces persistent cerebrovascular endothelial senescence, upregulated DNA-damage checkpoints with downregulated DNA-repair genes, and selective small-tracer BBB leak, whereas vincristine does not, framing chemo as a driver of a vascular-aging-like phenotype.
Abstract
Chemotherapy-related cognitive impairment is increasingly recognized as a long-term consequence of cancer treatment, yet the contribution of the cerebrovascular system remains poorly defined. In this study, we investigated the long-term effects of clinically relevant treatment regimens with cyclophosphamide (CP) and vincristine (VIN) on cerebrovascular cellular senescence, associated molecular signatures, and downstream functional outcomes, including disruption of blood-brain barrier (BBB) integrity in a mouse model. Our results showed that CP induces a persistent cerebrovascular endothelial phenotype characterized by increased cellular senescence, upregulation of mRNA expression of DNA damage checkpoint regulators, and concomitant downregulation of key DNA repair genes. BBB integrity was preserved after CP treatment for larger molecular tracers (40 kDa and 3 kDa) but exhibited increased permeability to small tracers (0.3 kDa), measured by in vivo two-photon microscopy, indicating a subtle yet persistent disruption of barrier function. In contrast, VIN elicited a markedly attenuated and heterogeneous transcriptional response and did not produce detectable BBB impairment, underscoring agent-specific cerebrovascular effects of chemotherapy. Collectively, these findings suggest that chemotherapy induces a persistent cerebrovascular injury phenotype with features resembling vascular aging and reduced vascular resilience, providing a potential mechanistic link between systemic cancer therapy and long-term adverse effects on brain health.
Why this matters
Chemotherapy survivorship cognitive complaints have been variously attributed to neuronal, glial, or immune mechanisms; this preclinical work localizes a persistent lesion to the cerebrovascular endothelium itself and ties it to a senescence/DNA-repair-collapse program resembling vascular aging. By showing cyclophosphamide produces the phenotype while vincristine does not, it argues chemo-induced accelerated vascular aging is agent-specific rather than a generic cytotoxic effect, which matters for both mechanism (which drugs load the senescent burden) and candidate rescue (senolytics or BBB-targeted interventions in survivors).